Stablix at TPD Summit 2026

Oct 26–29, 2026 Boston, MA ~300 attendees Website

Stablix takes part in 2 sessions at TPD Summit 2026 in Boston. Its sessions cover DUBTACs, molecules that stabilize proteins by recruiting deubiquitinases, on their way to clinical candidates, and the trends shaping the induced proximity field.

OrganizationTPD Summit 2026 Attendance
stablix.com
Biotech
Develops targeted protein stabilization therapeutics that recruit deubiquitinases to rescue proteins rather than degrade them.
Panel
Tue Oct 27
9:00am
Navigating the Evolving Induced Proximity Landscape: Trends, Opportunities & Global Impact
Plenary · with Nurix Therapeutics, Foghorn Therapeutics, C4 Therapeutics +1 more
Investment, partnering & strategy
Talk
Wed Oct 28
2:00pm
The Journey to DUBTAC Clinical Candidates
Track B: Pre-Clinical Development
Induced proximity beyond degradation

Explore the full TPD Summit 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full TPD Summit 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Stablix

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction